{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:24:43Z","timestamp":1770906283705,"version":"3.50.1"},"reference-count":34,"publisher":"Tech Science Press","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.061812","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:47:12Z","timestamp":1745556432000},"page":"1495-1503","source":"Crossref","is-referenced-by-count":2,"title":["Intradermal priming to intravesical Bacillus Calmette-Gu\u00e9rin in non-muscle invasive bladder cancer: A translational research and phase I clinical trial"],"prefix":"10.32604","volume":"33","author":[{"given":"LUCIANA","family":"SABOYA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEINI","family":"BUOSI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIAGO","family":"SILVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELAINE","family":"CANDIDO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOSIANE","family":"MORARI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LICIO A.","family":"VELLOSO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHAHROKH F.","family":"SHARIAT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARCUS V.","family":"SADI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEONARDO O.","family":"REIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: an update","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"},{"key":"ref2","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"2024 CA Cancer J Clin"},{"key":"ref3","first-page":"89","article-title":"Experimental and new approaches for bladder preservation in intermediate and high-risk non-muscle-invasive bladder cancer (NMIBC)","volume":"16","author":"Avilez","year":"2024","journal-title":"Res Rep Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","article-title":"NCCN guidelines\u00ae insights: bladder cancer, version 3.2024","volume":"22","author":"Flaig","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1016\/j.vaccine.2021.09.053","article-title":"Effects of Mycobacterium bovis Calmette et Gu\u00e9rin (BCG) in oncotherapy: bladder cancer and beyond","volume":"39","author":"Mukherjee","year":"2021","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1590\/s1677-5538.ibju.2021.02.02","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) Brazilian backstage in bladder cancer","volume":"47","author":"Korkes","year":"2021","journal-title":"Int Braz J Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1590\/S1677-5538.IBJU.2015.0122","article-title":"Are we following the guidelines on non-muscle invasive bladder cancer?","volume":"42","author":"Reis","year":"2016","journal-title":"Int Braz J Urol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/WON.0000000000000996","article-title":"Validation of visual prostate symptom score (VPSS) in Brazilian sample population","volume":"50","author":"Lopes","year":"2023","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/JLB.3MR0420-305R","article-title":"Multiple roles of caspase-8 in cell death, inflammation, and innate immunity","volume":"109","author":"Orning","year":"2021","journal-title":"J Leukoc Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e139837","DOI":"10.1172\/jci.insight.139837","article-title":"Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic-induced necroptosis","volume":"5","author":"Uzunparmak","year":"2020","journal-title":"JCI Insight"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.celrep.2015.09.048","volume":"13","author":"Ranjbar","year":"2015","journal-title":"Cell Rep"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1038\/s41467-022-32587-4","article-title":"IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses","volume":"13","author":"Clement","year":"2022","journal-title":"Nat Commun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/cas.16393","article-title":"Phospholipase D2 downregulates interleukin-1\u03b2 secretion from tumor-associated macrophages to suppress bladder cancer progression","volume":"116","author":"Hamada","year":"2025","journal-title":"Cancer Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/1078-0432.CCR-20-1610","article-title":"Blocking IL1 beta promotes tumor regression and remodeling of the myeloid compartment in a renal cell carcinoma model: multidimensional analyses","volume":"27","author":"Aggen","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2006529","DOI":"10.1080\/2162402X.2021.2006529","article-title":"CD122-targeted interleukin-2 and \u03b1PD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation","volume":"10","author":"Reyes","year":"2021","journal-title":"Oncoimmunology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","article-title":"CD25-treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity","volume":"1","author":"Solomon","year":"2020","journal-title":"Nat Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e171164","DOI":"10.1172\/JCI171164","article-title":"YAP1 induces bladder cancer progression and promotes immune evasion through IL-6\/STAT3 pathway and CXCL deregulation","volume":"135","author":"Sadhukhan","year":"2024","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"104254","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e003416","DOI":"10.1136\/jitc-2021-003416","article-title":"Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer","volume":"10","author":"Xu","year":"2022","journal-title":"J Immunother Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e12830","DOI":"10.1111\/sji.12830","article-title":"Tumour-associated B cells in urothelial urinary bladder cancer","volume":"91","author":"Zirakzadeh","year":"2020","journal-title":"Scand J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"dmm050693","DOI":"10.1242\/dmm.050693","article-title":"Macrophages directly kill bladder cancer cells through TNF signaling as an early response to BCG therapy","volume":"17","author":"Mart\u00ednez-L\u00f3pez","year":"2024","journal-title":"Dis Model Mech"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-2.16102","article-title":"Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage","volume":"43","author":"Yakovlev","year":"2021","journal-title":"Exp Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1878-0261.13699","article-title":"Enhancing immunotherapy through PD-L1 upregulation: the promising combination of anti-PD-L1 plus mTOR inhibitors","volume":"19","author":"Hern\u00e1ndez-Prat","year":"2025","journal-title":"Mol Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41590-021-00896-3","article-title":"The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-\u03b2 pathway","volume":"22","author":"Takahashi","year":"2021","journal-title":"Nat Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4081\/aiua.2021.2.148","article-title":"Gas6 expression and Tyrosine kinase Axl Sky receptors: their relation with tumor stage and grade in patients with bladder cancer","volume":"93","author":"Akg\u00fcl","year":"2021","journal-title":"Arch Ital Urol Androl"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"110534","DOI":"10.1016\/j.isci.2024.110534","article-title":"Activation of limbal epithelial proliferation is partly controlled by the ACE2-LCN2 pathway","volume":"27","author":"Jiang","year":"2024","journal-title":"iScience"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1016\/j.vaccine.2022.06.039","article-title":"BCG vaccine safety in COVID-19 convalescent adults: battle a randomized controlled trial","volume":"40","author":"Dionato","year":"2022","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-5347(17)55282-9","article-title":"Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer","volume":"124","author":"Lamm","year":"1980","journal-title":"J Urol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-5347(17)52736-6","article-title":"Experience with Bacillus Calmette-Guerin in patients with superficial bladder carcinoma","volume":"128","author":"Brosman","year":"1982","journal-title":"J Urol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.juro.2008.11.124","article-title":"Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer","volume":"181","author":"Bisiaux","year":"2009","journal-title":"J Urol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/1078-0432.CCR-14-1781","article-title":"Sequential intravesical mitomycin plus Bacillus Calmette-Gu\u00e9rin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial","volume":"21","author":"Svatek","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.31083\/j.fbl2908295","article-title":"Update on the mechanism of action of intravesical BCG therapy to treat non-muscle-invasive bladder cancer","volume":"29","author":"Abou Chakra","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"137ra72","DOI":"10.1126\/scitranslmed.3003586","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"Biot","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1614857","DOI":"10.1080\/2162402X.2019.1614857","article-title":"Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial","volume":"8","author":"Ji","year":"2019","journal-title":"Oncoimmunology"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-6\/OncolRes-33-06-61812\/OncolRes-33-61812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:34:50Z","timestamp":1763343290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n6\/61346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.061812","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}